Dear Friends and Colleagues,
It is a great pleasure to invite Researchers from Academia and industry and clinicians from all over the world to the 7th Advances in Circulating Tumor Cells meeting: “Liquid Biopsy: from bench to Bedside” that will be held on Sep 24-27/2025 in the beautiful city of Thessaloniki, Greece.
Liquid biopsy has already revealed its tremendous potential to significantly change the therapeutic strategy and management of cancer patients. The 7th ACTC meeting (www.actc2025.org) will focus on the latest advances on liquid biopsy basic research, state of the art technologies, and clinical applications in many types of cancer, from bench to bedside.
We aim to bring together again a critical mass of Key Opinion Leaders in the field, world-top liquid biopsy clinicians and researchers, postgraduate students, and technology providers, so that we will all have again the chance to interact, establish fruitful collaborations and present state of the art data and technology innovations in the field in a highly safe, relaxing and stimulating environment. During intense keynote, oral and poster presentation sessions, mostly unpublished cutting-edge research on the latest achievements, and technical advancements on CTCs, ctDNA and EVs analysis, will be presented. Latest findings on clinical trials based on liquid biopsy will be discussed. Three travel grants and three poster awards will be granted to the best submitted abstracts that will be evaluated by the International Scientific Committee members. More importantly, the 7th ACTC meeting aims to give all participants the chance to establish strong collaborations and networks in a unique, relaxing and stimulating environment.
I am looking forward to welcoming you in Thessaloniki on September 24-27 2025!!
Warm regards,
Evi S. Lianidou, PhD
University of Athens, Greece
It is a great pleasure to invite Researchers from Academia and industry and clinicians from all over the world to the 7th Advances in Circulating Tumor Cells meeting: “Liquid Biopsy: from bench to Bedside” that will be held on Sep 24-27/2025 in the beautiful city of Thessaloniki, Greece.
Liquid biopsy has already revealed its tremendous potential to significantly change the therapeutic strategy and management of cancer patients. The 7th ACTC meeting (www.actc2025.org) will focus on the latest advances on liquid biopsy basic research, state of the art technologies, and clinical applications in many types of cancer, from bench to bedside.
We aim to bring together again a critical mass of Key Opinion Leaders in the field, world-top liquid biopsy clinicians and researchers, postgraduate students, and technology providers, so that we will all have again the chance to interact, establish fruitful collaborations and present state of the art data and technology innovations in the field in a highly safe, relaxing and stimulating environment. During intense keynote, oral and poster presentation sessions, mostly unpublished cutting-edge research on the latest achievements, and technical advancements on CTCs, ctDNA and EVs analysis, will be presented. Latest findings on clinical trials based on liquid biopsy will be discussed. Three travel grants and three poster awards will be granted to the best submitted abstracts that will be evaluated by the International Scientific Committee members. More importantly, the 7th ACTC meeting aims to give all participants the chance to establish strong collaborations and networks in a unique, relaxing and stimulating environment.
I am looking forward to welcoming you in Thessaloniki on September 24-27 2025!!
Warm regards,
Evi S. Lianidou, PhD
University of Athens, Greece
